Enhanced adenosine A2B mediated coronary response in reserpinised rat heart

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 367, Issue 3, 2003, Pages 266-273

  Rose'Meyer, Roselyn B ^a   Harrison, Glenn J ^a   Headrick, John P ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Adenosine; Ischaemia reperfusion; Rat isolated heart; Reserpine

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 8 (3 CHLOROSTYRYL)CAFFEINE; ADENOSINE A2B RECEPTOR; CATECHOLAMINE; FLAVINE MONONUCLEOTIDE; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DRUG RECEPTOR BINDING; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HYPEREMIA; ISOLATED HEART; MALE; NONHUMAN; RAT;

ADENOSINE; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; FLAVINS; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NOREPINEPHRINE; PURINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2B; REPERFUSION; RESERPINE; TIME FACTORS; TYRAMINE; VASODILATOR AGENTS;

EID: 0037356304     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-002-0678-z     Document Type: Article

References (34)

1. Belardinelli L, Isenberg G (1983) Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol 244:H734-H737
2. Belardinelli L, Shyrock JC, Song Y, Wang D, Srinivas M (1995) Ionic basis of electrophysiological actions of adenosine on cardiomyocytes. FASEB J 9:359-365
3. 2b adenosine receptor in NIH 3T3 fibroblasts. Biochem Pharmacol 47:801-814
4. Burgdorf C, Richardt D, Kurz T, Seyfarth M, Jain D, Katus HA, Richardt G (2001) Adenosine inhibits noradrenaline release in the postischemic rat heart: the mechanism of neuronal stunning. Cardiovasc Res 49:713-720
5. Burnstock G (1995) Noradrenaline and ATP: cotransmitters and neuromodulators. J Physiol Pharmacol 46:365-384
6. Carlsson L, Graefe K-H, Trendelenburg U (1987) Early intraneuronal mobilisation and deamination of noradrenaline during global ischemia in the isolated perfused rat heart. Acta Physiol Scand Suppl 559:1-85
7. Collis MG, Hourani SMO (1993) Adenosine receptor subtypes. Tips 14:360-366
8. Dobson JG (1983) Adenosine reduces catecholamine contractile responses in oxygenated and hypoxic atria. Am J Physiol 245: H468-H474
9. 2B receptors. Pharmacol Rev 49:381-402
10. Fredholm BB, Abbrachio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156
11. Harrison GJ, Harden FA, Jordan LR, Varela JI, Willis RJ (1996) A method to evaluate the response of the coronary circulation of perfused rat heart to adenosine. Can J Physiol Pharmacol 74:145-149
12. Harrison GJ, Willis RJ, Headrick JP (1998) Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc Res 40:74-87
13. Hinschen AK, Rose'Meyer RB, Headrick JP (2001) Age-related changes in adenosine-mediated relaxation of coronary and aortic smooth muscle. Am J Physiol 280:H2380-H2389
14. Jacobson KA, Nikodijevic O, Padgett WL, Gallo-Rodriguez C, Maillard M, Daly JW (1993a) 8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo. FEBS Lett 323:141-144
15. Jacobson KA, Gallo-Rodriguez C, Melman N, Fischer B, Maillard M, van Bergen A, van Galen PJ, Karton Y (1993b) Structure activity relationships of 8-styrlxanthines as A2-selective adenosine antagonists. J Med Chem 36:1333-1342
16. Jacobson KA, Park KS, Jiang JL, Kim YC, Olah ME, Stiles GL, Ji XD (1997) Pharmacological characterization of novel A3 adenosine receptor-selective antagonists. Neuropharmacology 36:1157-1165
17. Lorbar M, Fenton RA, Dobson JG (1999) ATP as a source of interstitial adenosine in the rat heart. Can J Physiol Pharmacol 77:579-588
18. Norton GR, Woodiwiss AJ, McGinn RJ, Lorbar M, Chung ES, Honeyman TW, Fenton RA, Dobson JG Jr, Meyer TE (1999) Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in the rat heart. Am J Physiol 276:H341-H349
19. Olah ME, Stiles GL (1995) Adenosine receptor subtypes; characterization and therapeutic regulation. Ann Rev Pharmacol Toxicol 35:581-606
20. Peachey JA, Hourani SMO, Kitchen I (1994) The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations. Br J Pharmacol 113:1249-1256
21. Poucher SM, Keddie JR, Sing P, Stoggal SM, Caulkett PWR, Jones G, Collis MG (1995) The in vitro pharmacology of ZM 241385, a potent, non-xanthine, A2a selective adenosine receptor antagonist. Br J Pharmacol 115:1096-1102
22. Ribeiro JA, Sebastiao AM (1986) Adenosine receptors and calcium: basis for proposing a third (A3) receptor. Prog Neurobiol 26:179-209
23. Rose'Meyer RB, Harden FA, Varela JI, Harrison GJ, Willis RJ (1999) Age related changes in adenosine in rat coronary resistance vessels. Gen Pharmacol 32:35-40
24. Schomig A, Dart AM, Dietz R, Kubler W, Mayer EJ (1985) Paradoxical role of neuronal uptake for the locally mediated release of endogenous noradrenaline in the ischemic myocardium. J Cardiovasc Pharm 7 [Suppl 5]:S40-S44
25. Sharma A, Singh M (1997) The possible role of adrenergic component in ischemic preconditioning. Meth Find Exp Clin Pharmacol 19:493-499
26. Shyrock JC, Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology and pharmacology. Am J Cardiol 79:2-10
27. Talukder MAH, Morrison RR, Jacobson MA, Jacobson KA, Ledent C, Mustafa SJ (2002) Targeted deletion of adenosine A3 receptor augments adenosine-induced coronary flow in isolated mouse heart. Am J Physiol Circ Physiol 282:H2183-H2189
28. 1 receptor and of catecholinergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino) tetralin in the rat. Eur J Pharmacol 106:271-282
29. Wangler RD, DeWitt DF, Sparks HV Jr (1984) Effect of β-adrenergic blockade on nucleoside release from the hypoperfused isolated heart. Am J Physiol 247:H330-H336
30. Weselcouch EO, Baird AJ, Sleph PG, Dzwonczyk S, Murray HN, Grover GJ (1995) Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart. Cardiovasc Res 29:126-132
31. Winter CB, Cleveland JC, Butler KL, Bensard DB, Mitchell MB, Harken AH, Banerjee A (1997) Facilitative interactions between noradrenergic and purinergic signalling during preconditioning of the rat heart. J Mol Cell Cardiol 29:163-173
32. Wollenberger A, Krause EG, Heier G (1969) Stimulation of 3′,5′ cyclic AMP formation in dog myocardium following arrest of blood flow. Biochem Biophys Res Commun 36:664-670
33. Zhao Z, Francis CE, Ravid K (1997) An A3-subtype adenosine receptor is highly expressed in rat vascular smooth muscle cells: its role in attenuating adenosine-induced increase in cAMP. Microvasc Res 54:243-252
34. Zocchi C, Ongini E, Conti A, Monopoli A, Negretti A, Baraldi PG, Dionisotti S (1996) The non-selective heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. J Pharm Exp Ther 276:398-404